Weight loss increases circadian gene expression and emotional well-being in individuals with obesity
Year: 2025
Type: article
Study design: Clinical Trial
Abstract: Introduction Obesity is associated with disruptions in circadian rhythms and emotional well-being that can contribute to metabolic and psychological health issues. This study aimed to investigate the effects of weight loss by a dietary intervention on circadian gene expression and emotional state in individuals with obesity. Methods Fifty subjects with obesity followed a dietary intervention for 6 months. Anthropometric and biochemical parameters were assessed. Sleep quality was measured using a sleep questionnaire and Rosemberg Self-Esteem Scale, Beck Depression Inventory and State-Trait Anxiety Inventory (STAI) were used. PBMCs’ RNA was analyzed for circadian-related gene expression. Results Participants lost 11.3% body weight, along with reductions in lipid, carbohydrate metabolism and inflammation markers. Sleep quality improved; as poor sleep frequency was reduced, though sleep duration was similar. Self-esteem did not significantly increase; however, the proportion of participants with high self-esteem rose from 62 to 69% ( χ 2 = 12.5, p < 0.05). State anxiety decreased (STAI-S, p < 0.01), though trait anxiety remained stable. Several circadian genes were upregulated, including CLOCK , ARNTL , CRY1 , DBP , and NR1D1 ; with associations found between CLOCK and lower state anxiety at baseline, and between CRY2 and higher self-esteem and lower depression at baseline ( p < 0.05). Conclusion The dietary intervention influenced positively the metabolic, psychological, and circadian rhythm marker profile, highlighting potential interconnections between metabolism, circadian gene expression, and mental well-being. Clinical Trial Registration Identifier NCT06279780
Source: Frontiers in Nutrition
Language: English
Subfield: Endocrine and Autonomic Systems
Field: Neuroscience
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,801
Funders: European Commission, Generalitat Valenciana, Universitat de València, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana, HORIZON EUROPE Framework Programme, Instituto de Salud Carlos III, European Regional Development Fund
Awards: G1144605936, MICROBIOTA, FUNCIÓN MITOCONDRIAL Y SALUD METABÓLICA EN LA OBESIDAD, Efecto del tratamiento periodontal no quirúrgico sobre la respuesta inmune innata y adquirida desde una perspectiva de género: Posibles implicaciones terapéuticas de los miRNAs, G495259313, G5254703431, G6605821054, Health Outcomes from Raised Urban Settings, Nuevas estratégicas de intervención dietética sobre la microbiota intestinal para mejorar la salud mental en sujetos con obesidad: Potencial terapéutico de un simbiótico, G759215502, G7986115, Nuevas perspectivas en la relación mitofagia, autofagia y disfunción mitocondrial en la diabetes tipo 2: implicaciones clínicas y complicaciones cardiovasculares asociadas, Papel de la Microbiota, Inflamación y Estrés oxidativo en la fisiopatología de la Obesidad: Potencial terapéutico de los Flavonoides cítricos
OpenAlex ID: W4416730587
